What type of contract manufacturing solutions does API provide?
From preclinical to commercial manufacturing, our facilities and technical capabilities support the entire drug development lifecycle. We are equipped to handle complex projects including small molecule active pharmaceutical ingredients and sterile injectables, ensuring reliability, safety, and compliance at every step.

Product Types
Formulations
- Oral Solid Dosages (Capsules, Tablets, Powders)*
- Liquid Dosages (Solutions, Suspensions, Emulsions)*
- Topical Applications (Ointments, Creams)*
- Sterile Injectables**
- mRNA and Biologics**
*phase-appropriate GMP to Phase 2
**large-scale commercial capacity available mid 2026
Natural and Specialty Products (chemical synthesis)
- Natural Health Products (NHPs)
- Active Pharmaceutical Ingredients (APIs)
Custom and Specialized Solutions
- Custom Compounding
- Formulation Development for Emerging Needs

Contract Manufacturing Services
Clinical Trial Manufacturing
Our clinical trial material manufacturing capabilities are designed for precision and flexibility.
- Product Type: Active drug products delivered as capsules, tablets, gels, creams, or injectables.
- Placebo Manufacturing: Placebo dosage form design and manufacturing to match your active drug product, for placebo controlled clinical trials.
- Stability Testing: Quality controlled stability studies to determine the shelf life of your active drug products and placebos.
- Packaging and Labeling: Clinical trial ready capsules, tablets, tubes, and blister packs (active and placebo).
- Controlled Substance Manufacturing: Specialized handling of potent APIs and controlled substances.
- Health Canada Licensing: Commercial Drug Establishment License, Natural Health Product Site License, and Controlled Substances License.
Prototype Production
Our facilities at the University of Alberta and Life Sciences Campus at Edmonton Research Park bridge the gap between R&D and commercial production.
- API Synthesis: Up to 20L batch size of active pharmaceutical ingredient synthesis, supporting early clinical phases.
- NHP Manufacturing: Development and GMP production of NHPs and OTC products.
- Liquid Formulations: Expertise in solutions and suspensions.
- QC Testing Labs: Testing of raw materials, APIs, and finished dosage forms (injectables, solutions, suspensions).
Commercial-Scale Manufacturing
Our 83,000 sq. ft. GMP manufacturing facility within the Life Sciences Campus at Edmonton Research Park is designed to deliver sterile products, including injectables, for commercial markets, with capabilities for both small and large batch manufacturing.
- Aseptic Manufacturing: High-throughput production of sterile finished products with automated robotic filling lines.
- Product Types: Sterile injectables in vials (1–20 mL) or bottles (20–100 mL), solutions, powders, and emulsions.
- Annual Capacity: Up to 73.2 million doses per annum, and a sprint capacity that can meet the demands of the entire Canadian population for a critical product within 100 days.
- Advanced Testing and Quality Control: Micro laboratory support for sterile testing, environmental monitoring, and GMP compliance.
Warehouse and Distribution
- Secure storage of raw materials, APIs, and finished products.
- Streamlined import/export logistics to support global distribution.
End-to-End Early Discovery and Development Support
With the added expertise of our Early Discovery & Development, Regulatory & Quality, and Quantitative Solutions (QS) teams, we offer seamless integration across the innovation pipeline—from discovery and clinical strategy to manufacturing. Our comprehensive approach ensures a streamlined pathway for innovators, delivering tailored solutions for every stage of development to market.
Did you find the service that meets your needs?
Start your journey with us.
I’m ready to connectMeet Our Contract Manufacturing Solutions Team

Allan Aginski
Senior VP, Special Projects & Manufacturing
Read bioabout Allan Aginski
Allan Aginski
Senior VP, Special Projects & Manufacturing
Allan is a life sciences supply chain and manufacturing specialist with nearly 40 years of experience. He has established and run commercial life sciences company production facilities around the world, including for companies such as Abbott, Merck, and Genpharm. He has been responsible for the establishment of dozens of products in over 24 countries.

Hans Bauer
VP, Technical Operations
Read bioabout Hans Bauer
Hans Bauer
VP, Technical Operations
Hans brings over 25 years of experience in pharmaceutical manufacturing and quality, having worked with leading pharmaceutical companies in Europe, including Lonza, Sandoz (Novartis), Acino, and Akorn. He has a proven track record in managing large teams, complex projects, and overseeing comprehensive operations.
Hans has strong expertise in developing and implementing robust quality systems that meet stringent regulatory standards across several countries, including the US, EU, and Switzerland. His production expertise includes API-small molecule manufacturing, peptide chemical and biotechnology manufacturing, as well as the production of solid and semi-solid forms and sterile manufacturing.

Vijay Somayaji
Sr. Director, Product Development & Quality
Read bioabout Vijay Somayaji
Vijay Somayaji
Sr. Director, Product Development & Quality
Vijay has over 30 years experience in biotech research and development and QA/QC. With a PhD in Chemistry and post-doctoral work under Nobel Laureate Dr. H. C. Brown, Vijay has served in director level roles at Biomira, AltaRex, Novolytic, and Virexx. As an experienced QA, Vijay has supported product development for dozens of clinical programs taking place at sites around the world.

Daniel Trepanier
Executive Scientist, Preclinical Development
Read bioabout Daniel Trepanier
Daniel Trepanier
Executive Scientist, Preclinical Development
Over 25 years in the pharmaceutical industry. Experienced in pharmaceutical development including drug discovery, analytical and bioanalytical method development and analysis, preclinical pharmacokinetic, toxicological and toxicokinetic studies, formulation development, drug manufacturing and preclinical/clinical supply, preparation of preclinical regulatory submissions, interfacing with contract research organizations and patent attorneys. Real world experience in all aspects of drug development required to successfully move a drug from discovery, through myriad regulatory agency required studies, to Clinical Phase I/II status.
Ready to take your life sciences innovation to the next level?
Contact us today for a free 1-hour discovery consultation to determine how we can bring your idea to market together.